Cargando…

BDNF as a therapeutic candidate for cocaine use disorders

Cocaine self-administration disturbs intracellular signaling in multiple reward circuitry neurons that underlie relapse to drug seeking. Cocaine-induced deficits in prelimbic (PL) prefrontal cortex change during abstinence, resulting in different neuroadaptations during early withdrawal from cocaine...

Descripción completa

Detalles Bibliográficos
Autor principal: McGinty, Jacqueline F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195100/
https://www.ncbi.nlm.nih.gov/pubmed/37206683
http://dx.doi.org/10.1016/j.addicn.2022.100006
_version_ 1785044154233913344
author McGinty, Jacqueline F.
author_facet McGinty, Jacqueline F.
author_sort McGinty, Jacqueline F.
collection PubMed
description Cocaine self-administration disturbs intracellular signaling in multiple reward circuitry neurons that underlie relapse to drug seeking. Cocaine-induced deficits in prelimbic (PL) prefrontal cortex change during abstinence, resulting in different neuroadaptations during early withdrawal from cocaine self-administration than after one or more weeks of abstinence. Infusion of brain-derived neurotrophic factor (BDNF) into the PL cortex immediately following a final session of cocaine self-administration attenuates relapse to cocaine seeking for an extended period. BDNF affects local (PL) and distal subcortical target areas that mediate cocaine-induced neuroadaptations that lead to cocaine seeking. Blocking synaptic activity selectively in the PL projection to the nucleus accumbens during early withdrawal prevents BDNF from decreasing subsequent relapse. In contrast, blocking synaptic activity selectively in the PL projection to the paraventricular thalamic nucleus by itself decreases subsequent relapse and prior intra-PL BDNF infusion prevents the decrease. Infusion of BDNF into other brain structures at different timepoints after cocaine self administration differentially alters cocaine seeking. Thus, the effects of BDNF on drug seeking are different depending on the brain region, the timepoint of intervention, and the specific pathway that is affected.
format Online
Article
Text
id pubmed-10195100
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-101951002023-05-18 BDNF as a therapeutic candidate for cocaine use disorders McGinty, Jacqueline F. Addict Neurosci Article Cocaine self-administration disturbs intracellular signaling in multiple reward circuitry neurons that underlie relapse to drug seeking. Cocaine-induced deficits in prelimbic (PL) prefrontal cortex change during abstinence, resulting in different neuroadaptations during early withdrawal from cocaine self-administration than after one or more weeks of abstinence. Infusion of brain-derived neurotrophic factor (BDNF) into the PL cortex immediately following a final session of cocaine self-administration attenuates relapse to cocaine seeking for an extended period. BDNF affects local (PL) and distal subcortical target areas that mediate cocaine-induced neuroadaptations that lead to cocaine seeking. Blocking synaptic activity selectively in the PL projection to the nucleus accumbens during early withdrawal prevents BDNF from decreasing subsequent relapse. In contrast, blocking synaptic activity selectively in the PL projection to the paraventricular thalamic nucleus by itself decreases subsequent relapse and prior intra-PL BDNF infusion prevents the decrease. Infusion of BDNF into other brain structures at different timepoints after cocaine self administration differentially alters cocaine seeking. Thus, the effects of BDNF on drug seeking are different depending on the brain region, the timepoint of intervention, and the specific pathway that is affected. 2022-06 2022-01-26 /pmc/articles/PMC10195100/ /pubmed/37206683 http://dx.doi.org/10.1016/j.addicn.2022.100006 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Article
McGinty, Jacqueline F.
BDNF as a therapeutic candidate for cocaine use disorders
title BDNF as a therapeutic candidate for cocaine use disorders
title_full BDNF as a therapeutic candidate for cocaine use disorders
title_fullStr BDNF as a therapeutic candidate for cocaine use disorders
title_full_unstemmed BDNF as a therapeutic candidate for cocaine use disorders
title_short BDNF as a therapeutic candidate for cocaine use disorders
title_sort bdnf as a therapeutic candidate for cocaine use disorders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195100/
https://www.ncbi.nlm.nih.gov/pubmed/37206683
http://dx.doi.org/10.1016/j.addicn.2022.100006
work_keys_str_mv AT mcgintyjacquelinef bdnfasatherapeuticcandidateforcocaineusedisorders